"d ii) explore avenues for commercialisation of MEBsleep, in anticipation of FDA clearance. The funding secured during the June quarter will greatly assist in this endeavour, as well as continuing commercialisation efforts for ilumen™ and commencing the development of the Consumer App."
FDA approval expected early-mid next week.
Ann: Medibio Quarterly Update and Cashflow Report, page-3
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.4¢ | $30.27K | 889.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 364518 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 1080992 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| TRI (ASX) Chart |